CRISPR Therapeutics (CRSP) Insider Trading & Ownership → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Free crsp Stock Alerts $56.41 +0.75 (+1.35%) (As of 04/23/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media CRISPR Therapeutics (NASDAQ:CRSP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$13.30 M Get CRSP Insider Trade Alerts Want to know when executives and insiders are buying or selling CRISPR Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CRSP Insider Buying and Selling by Quarter Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. CRISPR Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/15/2024Samarth KulkarniCEOSell19,582$59.91$1,173,157.62 3/15/2024Raju PrasadCFOSell3,524$72.69$256,159.56 3/15/2024Samarth KulkarniCEOSell20,000$72.48$1,449,600.00 3/11/2024James R KasingerGeneral CounselSell2,801$78.26$219,206.26 3/11/2024Samarth KulkarniCEOSell9,802$78.26$767,104.52 2/20/2024James R KasingerGeneral CounselSell1,913$79.67$152,408.71 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/20/2024Samarth KulkarniCEOSell6,370$79.67$507,497.90 2/15/2024Samarth KulkarniCEOSell20,000$80.36$1,607,200.00 1/29/2024Samarth KulkarniCEOSell50,000$60.51$3,025,500.00 1/16/2024Samarth KulkarniCEOSell20,000$62.50$1,250,000.00 5/30/2023Samarth KulkarniCEOSell25,000$64.88$1,622,000.00 4/25/2023Samarth KulkarniCEOSell25,000$50.67$1,266,750.00 (Data available from 1/1/2013 forward) CRSP Insider Trading Activity - Frequently Asked Questions Who is on CRISPR Therapeutics's Insider Roster? The list of insiders at CRISPR Therapeutics includes Bradley J Phd Bolzon, James R Kasinger, Michael John Tomsicek, Raju Prasad, Rodger Novak, and Samarth Kulkarni. Learn more on insiders at CRSP. What percentage of CRISPR Therapeutics stock is owned by insiders? 4.10% of CRISPR Therapeutics stock is owned by insiders. Learn more on CRSP's insider holdings. Which CRISPR Therapeutics insiders have been selling company stock? The following insiders have sold CRSP shares in the last 24 months: James R Kasinger ($371,614.97), Raju Prasad ($256,159.56), and Samarth Kulkarni ($26,741,310.04). How much insider selling is happening at CRISPR Therapeutics? Insiders have sold a total of 453,992 CRISPR Therapeutics shares in the last 24 months for a total of $27,369,084.57 sold. More Insider Trading Tools from MarketBeat Related Companies: Halozyme Therapeutics Insider Trades Krystal Biotech Insider Trades Immunovant Insider Trades Revolution Medicines Insider Trades ImmunityBio Insider Trades Iovance Biotherapeutics Insider Trades SpringWorks Therapeutics Insider Trades Vaxcyte Insider Trades Apogee Therapeutics Insider Trades Arcellx Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NASDAQ:CRSP) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm PressThe Greatest Bull Market in Crypto History…Weiss RatingsThe Next Nvidia?InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISPR Therapeutics AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.